Log In
BCIQ
Print this Print this
 

Interleukin-6 (IL-6) receptor (CD126)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Interleukin-6 (IL-6) receptor (CD126)

BCIQ
Print ChartPrint this
0 0 1 0 0 0 1 0 1 0 1 0 0 0 0 2 3 3 4 2
Phases of DevelopmentPreclinicalPhase IPhase IIPhase IIIMarketed
Autoimmune

2

3

3

4

2

Cancer

1

0

0

0

0

Inflammation

0

1

0

1

0

Ophthalmic

0

0

1

0

0




 Products Targeting Interleukin-6 (IL-6) receptor (CD126)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$840.0M

$175.0M

$665.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today